CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 21 enrolled
Drug / intervention
Full Nicotine Cigarettes +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04999644
NCT04999644Early Ph 1Completed
CompareCT.gov

Reduced Nicotine Cigarette Purchasing Decisions

Johns Hopkins University·interventional·Posted Aug 11, 2021·Updated Feb 9, 2024

In Brief

A Early Phase 1 clinical trial evaluating Full Nicotine Cigarettes, Reduced Nicotine Cigarettes, and 2 other interventions for Tobacco Use Disorder. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Early Ph 1CompletedFinished
20222023202420252026
First PostedAug 11, 2021
Enrollment StartFeb 23, 2022
Primary CompletionMar 29, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.9 years ago

Interventions

Full Nicotine Cigarettesdrug

A full nicotine tobacco cigarette that will be smoked by participants

Reduced Nicotine Cigarettesdrug

A reduced nicotine tobacco cigarette that will be smoked by participants

Average Nicotine Expectancybehavioral

Participant instructed the cigarette is "the same level of nicotine as your usual brand."

Very Low Nicotine Expectancybehavioral

Participant instructed the cigarette is "a very low level of nicotine compared to your usual brand."